Scheld W M, Sande M A
J Clin Invest. 1983 Mar;71(3):411-9. doi: 10.1172/jci110785.
A rabbit model of pneumococcal meningitis was used to examine the importance of bactericidal vs. bacteriostatic antimicrobial agents in the therapy of meningitis 112 animals were infected with one of two strains of type III Streptococcus pneumoniae. Both strains were exquisitely sensitive to ampicillin, minimum inhibitory concentration (MIC)/minimum bactericidal concentration (MBC)<0.125 mug/ml. The activity of chloramphenicol against the two strains varied: strain(1)-MIC 2 mug/ml, MBC 16 mug/ml; strain(2)-MIC 1 mug/ml, MBC 2 mug/ml. Animals were treated with either ampicillin or chloramphenicol in dosages that achieved a peak bactericidal effect in cerebrospinal fluid (CSF) for ampicillin against both strains. Two different dosages were used for chloramphenicol. The first dosage achieved a peak CSF concentration of 4.4+/-1.1 mug/ml that produced a bacteriostatic effect against strain(1) and bactericidal effect against strain(2). The second dosage achieved a bactericidal effect against both strains (mean peak CSF concentration 30.0 mug/ml). All animals were treated intramuscularly three times a day for 5 d. CSF was sampled daily and 3 d after discontinuation of therapy for quantitative bacterial cultures. Results demonstrate that only antimicrobial therapy that achieved a bactericidal effect in CSF was associated with cure. Over 90% of animals treated with one of the bactericidal regimens (i.e., animals in which the bacterial counts in CSF dropped >5 log(10) colony-forming units [cfu]/ ml after 48 h) had sterile CSF after 5 d of treatment. On the other hand, the regimen that achieved bacteriostatic concentrations (CSF drug concentrations between the MIC and MBC) produced a drop of 2.4 log(10) cfu/ml by 48 h; however, none of the animals that survived had sterile CSF after 5 d. These studies clearly demonstrate in a strictly controlled manner that maximally effective antimicrobial therapy of experimental pneumococcal meningitis depends on achieving a bactericidal effect in CSF.
采用肺炎球菌性脑膜炎兔模型来研究杀菌性与抑菌性抗菌药物在脑膜炎治疗中的重要性。112只动物感染了两种III型肺炎链球菌菌株中的一种。两种菌株对氨苄西林均极为敏感,最低抑菌浓度(MIC)/最低杀菌浓度(MBC)<0.125μg/ml。氯霉素对两种菌株的活性有所不同:菌株(1)-MIC 2μg/ml,MBC 16μg/ml;菌株(2)-MIC 1μg/ml,MBC 2μg/ml。动物分别接受氨苄西林或氯霉素治疗,所用剂量能使氨苄西林在脑脊液(CSF)中达到针对两种菌株的峰值杀菌效果。氯霉素使用了两种不同剂量。第一种剂量使脑脊液峰值浓度达到4.4±1.1μg/ml,对菌株(1)产生抑菌作用,对菌株(2)产生杀菌作用。第二种剂量对两种菌株均产生杀菌作用(脑脊液平均峰值浓度为30.0μg/ml)。所有动物每天肌肉注射3次,持续5天。每天采集脑脊液样本,并在停药后3天采集样本进行定量细菌培养。结果表明,只有在脑脊液中达到杀菌效果的抗菌治疗才与治愈相关。超过90%接受一种杀菌方案治疗的动物(即脑脊液中细菌计数在48小时后下降>5 log₁₀集落形成单位[cfu]/ml的动物)在治疗5天后脑脊液无菌。另一方面,达到抑菌浓度(脑脊液药物浓度在MIC和MBC之间)的方案在48小时时使cfu/ml下降了2.4 log₁₀;然而,存活的动物在5天后脑脊液均未无菌。这些研究以严格控制方式清楚地表明,实验性肺炎球菌性脑膜炎的最大有效抗菌治疗取决于在脑脊液中达到杀菌效果。